Welcome to IJSDR UGC CARE norms ugc approved journal norms IJRTI Research Journal | ISSN : 2455-2631
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.15 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Issue: August 2022

Volume 7 | Issue 8

Impact factor: 8.15

Click Here For more Info

Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter

Copyright Infringement Claims
Indexing Partner
Published Paper Details
Paper Title: Mucormycosis Complicates India's COVID-19 Pandemic: A Review
Authors Name: Priya Jaswal , Anshumala , Dr. Jihlli Basu
Unique Id: IJSDR2106038
Published In: Volume 6 Issue 6, June-2021
Abstract: COVID-19 or SARS-COV-2 becomes the universal deadly health alarm from December 2019 to till date with the global cases record of 178,202,480 as well as India’s cases record of 29,762,793 till 18th June, 2021. As the country's health system tries to recover from corona crisis, another fungal threat comes in existence known as Mucormycosis or Black fungus Infection, especially affecting the Asian continents like India with the presents recorded updates of more than 10,000 infected cases. Mucormycosis is opportunity seeking fungal infection mainly affects immunocompromised population such as diabetic ketoacidosis patients and those whose immunity has been already hijacked via SARS-CoV-2 virus, creates the fungal entry roadmap from various routes like inhalation, ingestion or inoculation to rule over the body. In the present review, we enlightened the Covid-19 tuned mucormycosis Indian epidemic figures, causative aspects, molecular studies or pharmacological and non-pharmacological approaches. In addition we would also like to talk about the role of human body’s immune system and how to reconstruct our immunity both at physical and non-physical (molecular) level as a defending wall towards affection of this infection.
Keywords: Mucormycosis, immunocompromised, opportunity seeking, Pharmacological & Non-Pharmacological
Cite Article: "Mucormycosis Complicates India's COVID-19 Pandemic: A Review", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.6, Issue 6, page no.248 - 255, June-2021, Available :http://www.ijsdr.org/papers/IJSDR2106038.pdf
Downloads: 000101745
Publication Details: Published Paper ID: IJSDR2106038
Registration ID:193434
Published In: Volume 6 Issue 6, June-2021
DOI (Digital Object Identifier):
Page No: 248 - 255
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631

Click Here to Download This Article

Article Preview

Click here for Article Preview

Major Indexing from www.ijsdr.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

Track Paper
Important Links
Conference Proposal
DOI (A digital object identifier)

Providing A digital object identifier by DOI
How to GET DOI and Hard Copy Related
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Creative Commons License
This material is Open Knowledge
This material is Open Data
This material is Open Content
Social Media

Indexing Partner